Parkinson’s disease: a review of non-motor symptoms

References

• Muzerengi S, Lewis H, Edwards M, et al. Non-motor symptoms in Parkinson’s disease: an underdiagnosed problem. Aging Health 2006;2(6):967-82
   Google Scholar
• Barone P, Antonini A, Colosimo C, et al. The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 2009;24(11):1641-9
   PubMed Web of Science ®Google Scholar
• Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 2006;5(3):235-45
   PubMed Web of Science ®Google Scholar
• Schrag A. What contributes to quality of life in patients with Parkinson’s disease? J Neurol Neurosurg Psychiatry 2000;69(3):308-12
   PubMed Web of Science ®Google Scholar
• Lieberman A. Depression in Parkinson’s Disease - review. Acta Neurol Scand 2006;113:1-8
   PubMed Web of Science ®Google Scholar
• Hemmerle AM, Herman JP, Seroogy KB. Stress, depression and Parkinson’s disease. Exp Neurol 2011;233:79-86
   PubMed Web of Science ®Google Scholar
• Barone P. Treatment of depressive symptoms in Parkinson’s disease. Eur J Neurol 2011;18(1):11-15
   PubMed Web of Science ®Google Scholar
• Hou JG, Lai EC. Non-motor Symptoms of Parkinson’s Disease. Int J Gerontol 2007;1(2):53-64
   Web of Science ®Google Scholar
• Poewe W. Depression in Parkinson’s Disease. J Neurol 2007;254(Suppl 5):49-55
   Web of Science ®Google Scholar
• Constantinescu R. Update on the use of parmipexole in the treatment of Parkinson’s disease. Neuropsychiatr Dis Treat 2008;4(2):337-52
   PubMedGoogle Scholar
• Ballanger B, Broussolle E, Poisson A, et al. Functional imaging of non-motor signs in Parkinson’s disease. Elsevier 2011;315(2012):9-14
   Google Scholar
• Gallagher DA, Schrage A. Psyhosis, apathy, depression and anxiety in Parkinson’s disease. Neurobiol Dis 2012;46:581-9
   PubMed Web of Science ®Google Scholar
• Henderson R, Kurlan R, Kerson JM, et al. Preliminary examination of the comorbidity of anxiety and depression in Parkinson’s disease. J Neuropsychiatry Clin Neurosci 1992;4:257-64
   PubMed Web of Science ®Google Scholar
• Menza MA, Robertson-Hoffman DE, Bonaspace AS. Parkinson’s disease and anxiety: Comorbidity with depression. Biol Psychiatry 1993;34:465-70
   PubMed Web of Science ®Google Scholar
• Remy P, Doder M, Lees A, et al. Depression in Parkinson’s disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005;128(6):1314-22
   PubMed Web of Science ®Google Scholar
• Chen J, Marsh L. Anxiety in Parkinon’s disease: identification and management. Ther Adv Neurol Disord 2014;7(1):52-9
   PubMed Web of Science ®Google Scholar
• Shulman LM, Taback R, Rabinstein A, et al. Non-recognition of depression and other non-motor symoptoms in Parkinson’s disease. Parkinsonism Relat Dis 2002;8:193-7
   PubMed Web of Science ®Google Scholar
• Dujardin K, Sockeel P, Devos D, et al. Characteristics of apathy in Parkinson’s disease. Mov Disord 2007;22:778-84
   PubMed Web of Science ®Google Scholar
• Starkstein SE, Petracca G, Chemerinski E, et al. Syndromic validity of apathy in Alzheimer’s disease. Am J Psychiatry 2001;158:872-7
   PubMed Web of Science ®Google Scholar
• Pluck GC, Brown RG. Apathy in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2002;24:457-63
   Google Scholar
• Tekin S, Cummings JL. Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res 2002;53(2):647-54
   PubMed Web of Science ®Google Scholar
• Starkstein SE, Brockman S. Apathy and Parkinson’s disease. Cur Treat Options Neurol 2011;13:267-73
   PubMed Web of Science ®Google Scholar
• Santangelo G, Trojano L, Barone P, et al. Apathy in Parkinson’s disease: diagnosis, neuropsychological correlates, pathophysiology and treatment. Behaviour Neurol 2013;27:501-13
   PubMed Web of Science ®Google Scholar
• Leentjens A, Koester J, Fruh B, et al. The effect of pramipexole on mood and motivational symptoms in Parkinson’s disease: a meta-analysis of placebo-controlled studies. Clin Ther 2009;31:89-98
   PubMed Web of Science ®Google Scholar
• Thobois S, Lhommee E, Klinger H, et al. Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil. Brain 2013;136:1568-77
   PubMed Web of Science ®Google Scholar
• Cormier F, Muellner J, Corvol JC. Genetics of impulse control disorders in Parkinson’s disease. J Neurol Transm 2013;120:665-71
   PubMed Web of Science ®Google Scholar
• Voon V, Mehta AR, Hallet M. Impulse control disorders in Parkinsons’s disease: Recent advances. Cur Opin Neurol 2011;24:324-30
   PubMed Web of Science ®Google Scholar
• Weintraub D, Koester J, Potenza MN, et al. Impulse control disorders in Parkinson disease. Arch Neurol 2010;6(5):589-95
   Google Scholar
• Wu K, Politis M, Piccini P. Parkinson disease and impulse control disorders: A review of clinical features, pathophysiology and management. Postgrad Med J 2008;85:590-6
   Web of Science ®Google Scholar
• Bermejo PE, Ruiz Huete C, Anciones B. Zonisamide in managing impulse control disorders in Parkinson’s disease. J Neurol 2010;257:1682-5
   PubMed Web of Science ®Google Scholar
• Weintraub D, Stern MB. Psychiatric complications in parkinson disease. Am J Geriatr Psychiatry 2005;13:844-51
   PubMed Web of Science ®Google Scholar
• Niethammer M, Feigin A, Eidelberg D. Functional neuroimaging in Parkinson’s disease. Cold Spring Harb Perspect Med 2012;2(5):a009274
   Web of Science ®Google Scholar
• Todorova A, Jenner P, Chaudhuri KR. Non-motor Parkinson’s: integral to motor Parkinson’s, yet often neglected. Pract Nerol 2014;14:310-22
   PubMedGoogle Scholar
• Yarnall AJ, Rochester L, Burn DJ. Mild cognitive impairment in Parkinson’s disease. Age Aging 2013;42:567-76
   PubMed Web of Science ®Google Scholar
• Janvin CC, Larsen JP, Aarsland D, et al. Subtypes of mild cognitive impairment in Parkinson’s disease: progression to dementia. Mov Disord 2006;21:1343-9
   PubMed Web of Science ®Google Scholar
• Williams-Gray CH, Foltynie T, Brayne CE, et al. Evolution of cognitive dysfunction in an incident Parkinson’s disease cohort. Brain 2007;130:1787-98
   PubMed Web of Science ®Google Scholar
• Aarsland D, Bronnick K, Williams-Gray C, et al. Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 2010;75:1062-9
   PubMed Web of Science ®Google Scholar
• Muslimovic D, Post B, Speelman JD, et al. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005;65:1239-45
   PubMed Web of Science ®Google Scholar
• Mamikonyan E, Moberg PJ, Siderowf A, et al. Mild cognitive impairment is common in Parkinson’s disease patients with normal Mini-Mental State Examination (MMSE) scores. Parkinsonism Relat Disord 2009;15:226-31
   PubMed Web of Science ®Google Scholar
• Weintraub D, Doshi J, Koka D, et al. Neurodegeneration across stages of cognitive decline in Parkinson disease. Arch Neurol 2011;68:1562-8
   PubMed Web of Science ®Google Scholar
• Huang C, Mattis P, Tang C, et al. Metabolic brain networks associated with cognitive function in Parkinson’s disease. Neuroimage 2007;34:714-23
   PubMed Web of Science ®Google Scholar
• Irwin D, Lee VM, Trojanowski JQ. Parkinson’s disease dementia: convergence of a-synuclein, tau and amyloid-B pathologies. Nat Rev 2013;14:626-36
   Google Scholar
• Robottom BJ, Weiner WJ. Dementia in Parkinson’s disease. Int Rev Neurobiol 2009;84:229-44
   PubMed Web of Science ®Google Scholar
• Emre M. Dementia associated with Parkinson’s disease. Lancet Neurol 2003;2:229-37
   PubMed Web of Science ®Google Scholar
• Kurtz AL, Kaufer DI. Dementia in Parkinson’s disease. Cur Treat Option Neurol 2011;13:242-54
   PubMed Web of Science ®Google Scholar
• Dirnberger G, Jahanshahi M. Executive dysfunction in Parkinson’s disease: a review. J Neuropsychol 2013;7(2):193-224
   PubMed Web of Science ®Google Scholar
• Lokk J. Daytime sleepiness in elderly Parkinson’s disease patients and treatment with the psychostimulant modafinil: a preliminary study. Neuropsychiatr Dis Treat 2010;6:93-7
   PubMed Web of Science ®Google Scholar
• Jahan I, Hauser RA, Sullivan KL, et al. Sleep disorders in Parkinson’s disease. Neuropsychiatr Dis Treat 2009;5:535-40
   PubMed Web of Science ®Google Scholar
• Marion M, Qurashi M, Marhsall G, et al. Is REM sleep behaviour disorder (RBD) a risk factor of dementia in idiopathic Parkinson’s disease? J Neurol 2008;255:192-6
   PubMed Web of Science ®Google Scholar
• Avidan A, Malhotra R. Neurodegenerative disease and REM behavior disorder. Sleep Disord 2012;14:474-92
   Google Scholar
• Videnovic A, Comella CL. Sleep disorders in Parkinson’s disease. Handb Clin Neurol 2011;99(3):997-1010
   PubMedGoogle Scholar
• Jellinger K. The pathomechanisms underlying Parkinson’s disease. Expert Rev Neurother 2014;14(2):199-215
   PubMed Web of Science ®Google Scholar
• Golombek D, Videnovic A. Circadian and sleep disorders in Parkinson’s Disease. Exp Neurol 2013;243:45-56
   PubMed Web of Science ®Google Scholar
• Comella CL. Treatment of restless legs syndrome. Neurotherapeutics 2014;11:177-87
   PubMed Web of Science ®Google Scholar
• Rana AQ, Siddiqui I, Mosabbir A, et al. Association of pain, Parkinson’s disease, and restless leg syndrome. J Neurol Sci 2013;327:32-4
   PubMed Web of Science ®Google Scholar
• Lipford MC. SilberMH. Long-term use of pramipexole in management of restless legs syndrome. Sleep Med 2012;13:1280-5
   PubMed Web of Science ®Google Scholar
• Saletu M, Anderer P, Saletu-Zyhlarz GM, et al. Comparative placebo-controlled polysomnographic and psychometric studies on the acute effects of gabapentin versus ropinirole in restless legs syndrome. J Neural Transm 2010;117:463-73
   PubMed Web of Science ®Google Scholar
• Trenkwalder C, Benes H, Grote L, et al. Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebocontrolled trial with an open-label extension. Lancet Neurol 2013;12:1141-50
   PubMed Web of Science ®Google Scholar
• Spillantini MG, Crowther RA, Jakes R, et al. Alpha-synuclein in filamentous inclusions of Lewy Bodies from Parkinson’s disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 1998;95(22):6469-73
   PubMed Web of Science ®Google Scholar
• Goldstein D, Jain S. Cardiovascular dysautonomia in Parkinson Disease: from pathophysiology to pathogenesis. Neurobiol Dis 2012;43(3):572-80
   Google Scholar
• Vaughan CP, Juncos JL, Burgio KL, et al. Behavioral therapy to treat urinary incontinence in Parkinson disease. Neurology 2011;76:1631-4
   PubMed Web of Science ®Google Scholar
• Vaughan C. What is the best approach for treating urinary incontinence in Parkinson’s disease? Aging Health 2012;8(5):525-95
   Google Scholar
• Winge K, Skau AM, Stimper H, et al. Prevalence of bladder dysfunction in Parkinson’s disease. Neurourol Urodyn 2006;25:116-22
   PubMed Web of Science ®Google Scholar
• Swinn L, Schrag A, Viswanathan R, et al. Sweating dysfunction in Parkinson’s disease. Mov Disord 2003;18:1459-63
   PubMed Web of Science ®Google Scholar
• Schestatsky P, Valls-Sole J, Ehlers JA, et al. Hyperhidrosis in Parkinson’s disease. Mov Disord 2006;21:1744-8
   PubMed Web of Science ®Google Scholar
• Katzenschlager R. Subcutaneous apomorphine infusion – an update. Eur Neurol Rev 2012;7(Suppl 1):8-12
   Google Scholar
• Martinez-Martin P, Damian J. Depression and anxiety in Parkinson’s disease. Nat Rev 2010;6:243-5
   Google Scholar
• Hobson P, Islam W, Roberts S, et al. The risk of bladder and autonomic dysfunction in a community cohort of Parkinson’s disease patients and normal controls. Parkinsonism Relat Disord 2003;10:67-71
   PubMed Web of Science ®Google Scholar
• Berardelli A, Rothwell JC, Thompson PD, et al. Pathophysiology of bradykinesia in Parkinson’s disease. Brain 2001;124:2131-46
   PubMed Web of Science ®Google Scholar
• Rana AQ, Yousuf MS, Awan N, et al. Impact of progression of Parkinson’s disease on drooling in various ethnic groups. Eur Neurol 2012;67:312-14
   PubMed Web of Science ®Google Scholar
• Bronner G, Royter V. Sexual dysfunction in Parkinson’s disease. J Sex Marital Ther 2004;30:95-105
   PubMed Web of Science ®Google Scholar
• Brown RG, Jahanshahi M, Quinn N, et al. Sexual function in patients with Parkinson’s disease and their partners. J Neurol Neurosurg Psychiatry 1990;53:480-6
   PubMed Web of Science ®Google Scholar
• Bronner G, Vodušek DB. Management of sexual dysfunction in Parkinson’s disease. Ther Adv Neurol Disord 2011;4(6):375-83
   PubMedGoogle Scholar
• Kaplan MS, Krueger RB. Diagnosis, assessment, and treatment of Hypersexuality. J Sex Res 2010;42(2-3):181-98
   Google Scholar
• Sharabi Y, Goldstein DS. Mechanisms of orthostatic hypotension and supine hypertension in Parkinson’s disease. J Neurol Sci 2011;310:123-8
   PubMed Web of Science ®Google Scholar
• Azulay JP, Witjas T, Eusebio A. Effect of subthalamic deep brain stimulation on non-motor fluctuations in Parkinson’s disease. J Neurol Transm 2013;120:655-7
   PubMed Web of Science ®Google Scholar
• Bayulkem K, Lopez G. Nonmotor fluctuations in Parkinson’s disease: Clinical spectrum and classification. J Neurol Sci 2010;289:89-92
   PubMed Web of Science ®Google Scholar
• Shulman LM, Singer C, Bean JA, et al. Internal tremor in patients with parkinson’s disease. Mov Disord 1996;11(1):3-7
   PubMed Web of Science ®Google Scholar
• Ha A, Jankovic J. Pain in parksinson’s Disease. Mov Disorders 2012;27(4):485-91
   PubMed Web of Science ®Google Scholar
• Ford B. Pain in Parkinson’s Disease. Mov Disord 2010;25(1):S98-2
   Web of Science ®Google Scholar
• Rana AQ, Kabir A, Jesudasan M, et al. Pain in Parkinson’s disease: Analysis and literature review. Clin Neurol Neurosurg 2013;115:2313-17
   PubMed Web of Science ®Google Scholar
• Chaudhuri R, Wallace V. Unexplained lower limb pain in Parkinson’s disease: A phenotypic variant of “painful Parkinson’s disease.”. Elsevier 2013;20(2014):122-4
   Google Scholar
• Braak H, Del Tredici K, Bratzke H, et al. Staging of the intercerebral inclusion body pathology associated with idiotpathic Parkinson’s disease (preclinical and clinical stages). J Neuropathol Exp Neurol 2002;249(Supple 3):III/1-5
   Google Scholar
• Muller A, Mungersdorf M, Reichmann H, et al. Olfactory function in parkinsonian syndromes. J Clin Neurosci 2002;9:521-4
   PubMed Web of Science ®Google Scholar
• Doty RL. Olfactory dysfunction in Parkinson disease. Nat Rev Neurol 2012;8:329-39
   PubMed Web of Science ®Google Scholar
• Jankovic J. Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatr 2008;68(4):368-76
   Google Scholar
• Haehner A, Hummel T, Reichmann H. Olfactory loss in Parkinson’s disease. Parkinsons Dis 2011;2011:1-6
   Google Scholar
• Pfiffer RF. Gastrointestinal dysfunction in Parkinson’s disease. Lancet Neurol 2003;2:107-16
   PubMed Web of Science ®Google Scholar
• Cersosimo MG, Benarroch EE. Pathological correlates of gastrointestinal dysfunction in Parkinson’s disease. Neurobiol Dis 2012;46:559-64
   PubMed Web of Science ®Google Scholar
• Zangaglia R, Martignoni E, Glorioso M, et al. Macrogol for the treatment of Constipation in parkinson’s disease. A randomized placebo-controlled study. Mov Disord 2007;22(9):1239-44
   PubMed Web of Science ®Google Scholar
• Salat-Foix D, Suchowerksy O. The management of gastrointestinal symptoms in Parkinson’s disease. Expert Rev Neurother 2012;12(2):239-48
   PubMed Web of Science ®Google Scholar
• Coates C, Bakheit AM. Dysphagia in Parkinson’s Disease. Eur Neurol 1997;38:49-52
   PubMed Web of Science ®Google Scholar
• Norman A, Leopold DO, Marion C, et al. Prepharyngeal dysphagia in Parkinson’s disease. Dysphagia 1996;11(1):14-22
   PubMed Web of Science ®Google Scholar
• Pfeiffer RF. Gastrointestinal dysfunction in Parkinson’s disease. Parkinsonism Relat Disord 2011;17:10-15
   PubMed Web of Science ®Google Scholar
• Biousse V, Skibell BC, Watts RL, et al. Ophthalmologic features of Parkinson’s disease. Neurology 2004;62(2):177-80
   PubMed Web of Science ®Google Scholar
• Kim YE, Jeon BS. Musculoskeletal problems in Parkinson’s disease. J Neural Transm 2013;120(4):537-42
   PubMed Web of Science ®Google Scholar
• Sato Y, Kaji M, Tsuru T, et al.Vitamin K. Deficiency and Osteopenia in Elderly Women with Parkinson’s Disease. Arch Phys Med Rehabil 2002;83:86-91
   PubMed Web of Science ®Google Scholar
• Chen PH, Wang RL, Liou DJ, et al. Gait Disorders in Parkinson’s Disease: Assessment and Management. Int Jour Geront 2013;7:189-93
   Web of Science ®Google Scholar
• Baik JS, Kim JY, Park JH, et al. Scoliosis in patients with Parkinson’s disease. J Clin Neurol 2009;5(2):91-4
   PubMed Web of Science ®Google Scholar
• Doherty KM, van de Warrenburg BP, Peralta MC, et al. Postural deformities in Parkinson’s disease. Lancet Neurol 2011;10(6):538-49
   PubMed Web of Science ®Google Scholar
• Yuan-Yuan XU. The natural history of depression in Parkinson’s Disease within 30-month follow up. Parkinson’s Disease 2015;2015(362892):7
   Google Scholar
• Barker A, Lazar A, Overeem S, et al. ‘The clock that time us’- circadian rhythms in neurodegeneratice disorders. Nat Rev Neurol 2014;10(12):683-93
   PubMed Web of Science ®Google Scholar
• Bloem BR, Keus SH, Mulleners W, et al. Allied health care in Parkinson’s Disease: referral, consultation, and professional expertise. Mov Disord 2008;24(2):282-6
   Web of Science ®Google Scholar